Zenas BioPharma, Inc. (ZBIO) — Financial statements
Income statement, balance sheet, and cash flow for Zenas BioPharma, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 10↑100.0% | 5↓90.0% | 50 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 139 | 0.00↓100.0% | 62 | |
| Gross Profit | 10↑107.5% | -134↓368.3% | 50↑181.1% | -62 | |
| Operating Expenses | |||||
| R&D Expenses | 168↑20.8% | 139↑131.8% | 60↓4.2% | 63 | |
| General & Administrative Expenses | 53↑84.8% | 29↑68.6% | 17↑33.6% | 13 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 0.90 | 0.00↓100.0% | 0.70 | |
| SG&A Expenses | 53↑79.2% | 30↑73.8% | 17↑26.7% | 14 | |
| Other Expenses | 0.00↑100.0% | -139↓1491.4% | 10↑116.2% | -62 | |
| Operating Expenses | 221↑644.2% | 30↓65.9% | 87↑500.6% | 15 | |
| Total Costs & Expenses | 221↑31.1% | 169↑93.8% | 87↑14.4% | 76 | |
| Operating Results | |||||
| Operating Income | -211↓29.0% | -164↓341.2% | -37↑51.3% | -76 | |
| Depreciation & Amortization | 0.06↓59.1% | 0.14↑21.2% | 0.11↑44.9% | 0.08 | |
| EBITDA | -370↓126.2% | -164↓505.7% | -27↑64.0% | -75 | |
| EBIT | -370↓126.1% | -164↓503.7% | -27↑63.9% | -75 | |
| Interest & Other Income | |||||
| Net Interest Income | 5 | 0.00 | 0.00 | 0.00 | |
| Interest Income | 12 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 7 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 159 | 0.00↑100.0% | -10↓900.0% | -1 | |
| Other Income / Expenses | -166↓2370.9% | 7↑2162.0% | 0.32↑100.8% | -43 | |
| Income Before Tax | -378↓141.3% | -157↓325.2% | -37↑69.1% | -119 | |
| Income Tax Expense | -0.08↓118.4% | 0.43↑42.5% | 0.30 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -378↓140.6% | -157↓322.9% | -37↑68.9% | -119 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -378↓140.6% | -157↓322.9% | -37↑68.9% | -119 | |
| Bottom-Line Net Income | -378↓140.6% | -157↓322.9% | -37↑68.9% | -119 | |
| EPS (Basic) | -8.44↓124.5% | -3.76↓287.6% | -0.97↑68.8% | -3.11 | |
| EPS (Diluted) | -8.44↓124.5% | -3.76↓287.6% | -0.97↑68.8% | -3.11 | |
| Weighted Average Shares | 45↑7.0% | 42↑9.1% | 38↑0.0% | 38 | |
| Weighted Average Diluted Shares | 45↑7.0% | 42↑9.1% | 38↑0.0% | 38 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.